Alaunos Therapeutics Inc Capital Reinvestment Ratio

Latest as of September 2015: 0.00x

Alaunos Therapeutics Inc capital reinvestment ratio. Alaunos Therapeutics Inc (TCRT) has a Capital Reinvestment Ratio of 0.00x as of September 2015, meaning it reinvests 0% of its operating cash flow ($45.20 Million) in capital expenditures ($3.00K). Check cash flow reinvestment rate of Alaunos Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$45.20 Million

USD

Capital Expenditures

$3.00K

USD

Data as of

Sep 2015

Most recent filing

Alaunos Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Alaunos Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see TCRT cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow